Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学DLBCL Subtypes, ctDNA Lymphoma

Ash Alizadeh

MD PhD

🏢Stanford University🌐USA

Professor

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ash Alizadeh at Stanford has made major contributions to lymphoma molecular biology and liquid biopsy, including defining GCB (germinal center B-cell) and ABC (activated B-cell) DLBCL subtypes based on gene expression profiling — subtypes with different prognoses and drug sensitivities that inform treatment selection. He also pioneered ctDNA approaches for lymphoma monitoring, including showing that ctDNA dynamics predict treatment response before imaging.

Share:

🧪Research Fields 研究领域

DLBCL GCB ABC molecular subtypes
lymphoma ctDNA cell-free DNA
DLBCL genomic classification
diffuse large B-cell lymphoma biology
CLL ctDNA monitoring

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Ash Alizadeh 的研究动态

Follow Ash Alizadeh's research updates

留下邮箱,当我们发布与 Ash Alizadeh(Stanford University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment